Oct 25 (Reuters) - Oriola Oyj OKDBV.HE :
* ORIOLA CORPORATION'S INTERIM REPORT 1
JANUARY-30 SEPTEMBER 2019
* Q3 NET SALES EUR 429.0 MILLION VERSUS EUR 369.9 MILLION
YEAR AGO
* Q3 ADJUSTED OPERATING PROFIT EUR 9.8 MILLION VERSUS EUR
17.5
MILLION YEAR AGO
* BUSINESS OUTLOOK WAS CHANGED ON 19 JUNE 2019, AND ADJUSTED
EBIT
IS ESTIMATED TO DECREASE FROM 2018 LEVEL.
* ONLINE SALES GREW BY 33% AND ESPECIALLY SALES OF
PRESCRIPTION
MEDICINES WAS INCREASING
* PHARMA CONTINUED STRONG GROWTH IN BOTH OPERATING COUNTRIES
* ORIOLA'S STRATEGIC PROGRAMMES, 20BY20 EXCELLENCE AND
CUSTOMER
EXPERIENCE, ARE PROGRESSING ACCORDING TO PLAN
Source text for Eikon: ID:nWkr5x1SXn
Further company coverage: OKDBV.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))